[The antioxidant function of high density lipoproteins: a new paradigm in atherosclerosis]
- PMID: 15225502
[The antioxidant function of high density lipoproteins: a new paradigm in atherosclerosis]
Abstract
The one disease associated with the greatest morbidity and mortality in industrialized countries is coronary heart disease (CHD). High density lipoprotein (HDL) is one of the most important independent protective factors for the arteriosclerosis which underlies CHD. Paraoxonase 1 (PON1) is an enzyme that confers antioxidant properties to HDL. In vitro, PON1 hydrolyzes a large variety of endogenous or exogenous substrates, some of which are clearly involved in the progression of arteriosclerosis. A close relationship between PON1 deficiency and accelerated progression of arteriosclerosis has been found in animal models. Moreover, PON1 activity is reduced in high oxidative stress diseases such as CHD, dyslipoproteinemias, inflammatory processes, diabetes and certain neuropathies. Reduced PON1 enzyme activity is associated with several arteriosclerosis-related diseases. The most thoroughly studied genetic variant of PON1 is PON1-192, in which the R allele is associated with elevated paraoxonase activity. This allele, present in 24.8% of the Italian population, is found in up to 78.9% of the population of Ecuadorian Cayapa Indians. A metaanalysis of studies on the relationship between CHD and the R allele showed the latter to be an independent risk factor for this disease, with an odds ratio of 1.18 (95% confidence interval, 1.10-1.27). The PON1 enzyme is a potentially useful new qualitative indicator in addition to the well known reverse cholesterol transport capacity associated with high plasma levels of HDL.
Similar articles
-
Variation in paraoxonase-1 activity and atherosclerosis.Curr Opin Lipidol. 2009 Aug;20(4):265-74. doi: 10.1097/MOL.0b013e32832ec141. Curr Opin Lipidol. 2009. PMID: 19550323 Review.
-
Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.Atherosclerosis. 2006 Jul;187(1):74-81. doi: 10.1016/j.atherosclerosis.2005.08.026. Epub 2005 Oct 17. Atherosclerosis. 2006. PMID: 16229851
-
Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.Clin Sci (Lond). 2005 Jun;108(6):497-506. doi: 10.1042/CS20040312. Clin Sci (Lond). 2005. PMID: 15634192
-
Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?Free Radic Biol Med. 2004 Nov 1;37(9):1317-23. doi: 10.1016/j.freeradbiomed.2004.07.034. Free Radic Biol Med. 2004. PMID: 15454272 Review.
-
Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.Circ Res. 2004 Oct 15;95(8):789-97. doi: 10.1161/01.RES.0000146031.94850.5f. Epub 2004 Sep 23. Circ Res. 2004. PMID: 15388641
Cited by
-
Sex-based association between high-density lipoprotein cholesterol and adverse outcomes after coronary artery bypass grafting.BMC Cardiovasc Disord. 2024 Apr 5;24(1):194. doi: 10.1186/s12872-024-03806-1. BMC Cardiovasc Disord. 2024. PMID: 38580951 Free PMC article.
-
Telomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trial.Cardiovasc Diabetol. 2024 Mar 16;23(1):98. doi: 10.1186/s12933-024-02175-5. Cardiovasc Diabetol. 2024. PMID: 38493287 Free PMC article. Clinical Trial.
-
Association between PON1-rs662 Gene Polymorphism and Diabetic Retinopathy in Population of the Qom, Iran.Avicenna J Med Biotechnol. 2023 Oct-Dec;15(4):253-257. doi: 10.18502/ajmb.v15i4.13500. Avicenna J Med Biotechnol. 2023. PMID: 38078345 Free PMC article.
-
Genetic polymorphisms in the angiotensin converting enzyme, actinin 3 and paraoxonase 1 genes in women with diabetes and hypertension.Arch Endocrinol Metab. 2023 Nov 10;68:e210204. doi: 10.20945/2359-4292-2021-0204. Arch Endocrinol Metab. 2023. PMID: 37948561 Free PMC article.
-
Therapeutic Efficacy of Boric Acid Treatment on Brain Tissue and Cognitive Functions in Rats with Experimental Alzheimer's Disease.Drug Des Devel Ther. 2023 May 17;17:1453-1462. doi: 10.2147/DDDT.S405963. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 37220543 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous